Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-VERAPAF: Verapamil vs Metoprolol in Paroxysmal Atrial Fibrillation
NCT07445789Phase 4Not yet recruiting
- Sponsor
- Martini Ziekenhuis
- Start
- Jun 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of verapamil in Atrial fibrillation (AFib), sponsored by Martini Ziekenhuis. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
verapamil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07445789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445789.